Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 1Phase 2/3 1

Status

Completed 18Recruiting 13Terminated 8Unknown 5Active not recruiting 3Withdrawn 2

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Plasma cell 2Other hematologic neoplasm 2Lymphoid 2

Conditions

Multiple Myeloma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Drug Therapy 219Cyclophosphamide 219Paclitaxel 205apatinib 201Bevacizumab 196camrelizumab 190Fluorouracil 188sintilimab 133Irinotecan 125Blood Specimen Collection 125Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 112Pemetrexed 108anlotinib 105S 1 (combination) 105Leucovorin 102Surveys and Questionnaires 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × OTHER × Hematopoietic Stem Cell Transplantation × Clear all
NCT01374841 2023-06-28

Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors

European Institute of Oncology

Phase 2 Unknown
20 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT02605460 2020-01-14

Chemo Sensitization Before Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia in Complete Remission

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Phase 2 Unknown
20 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02929615 2016-10-12

Study of Standard and Individualized Treatment Model for Relapse and Refractory Lymphatic System Malignant Tumors

Peking University

Phase 4 Unknown
50 enrolled
Lymphoid

Lymphoma

NCT00415987 2008-06-20

Hematopoietic Stem Cell Transplantation in Myeloma

Azienda Ospedaliera San Giovanni Battista

Phase 2/3 Unknown
Plasma cell

Multiple Myeloma

NCT00702247 2008-06-20

Tandem Autologous- Nonmyeloablative Allogeneic Transplant for Newly Diagnosed Multiple Myeloma (Trapianto Tandem Autologo-Allogenico Non Mieloablativo Nel Mieloma Alla Diagnosi)

Azienda Ospedaliera San Giovanni Battista

Phase 2 Unknown
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡